-
公开(公告)号:US11957893B2
公开(公告)日:2024-04-16
申请号:US16947944
申请日:2020-08-25
Applicant: Medtronic, Inc.
Inventor: Brad C. Tischendorf , John E. Kast , Thomas P. Miltich , Gordon O. Munns , Randy S. Roles , Craig L. Schmidt , Joseph J. Viavattine , Christian S. Nielsen , Prabhakar A. Tamirisa , Anthony M. Chasensky , Markus W. Reiterer , Chris J. Paidosh , Reginald D. Robinson , Bernard Q. Li , Erik R. Scott , Phillip C. Falkner , Xuan K. Wei , Eric H. Bonde , David A. Dinsmoor , Duane L. Bourget , Forrest C M Pape , Gabriela C. Molnar , Joel A. Anderson , Michael J. Ebert , Richard T. Stone , Shawn C. Kelley , Stephen J. Roddy , Timothy J. Denison , Todd V. Smith
CPC classification number: A61N1/02 , A61B17/00234 , A61N1/05 , A61N1/0551 , A61N1/36007 , A61N1/3605 , A61N1/36057 , A61N1/36067 , A61N1/36071 , A61N1/36139 , A61N1/37205 , A61N1/37223 , A61N1/37235 , A61N1/37247 , A61N1/3727 , A61N1/3754 , A61N1/3756 , A61N1/3787 , A61N1/36021 , A61N1/36053 , A61N1/37211 , A61N1/37518 , F04C2270/0421
Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
-
公开(公告)号:US11495988B2
公开(公告)日:2022-11-08
申请号:US17026117
申请日:2020-09-18
Applicant: Medtronic, Inc.
Inventor: Erik R. Scott , David A. Dinsmoor , Venkat R. Gaddam
IPC: A61N1/00 , H02J7/02 , H02J50/10 , H02J50/40 , A61N1/36 , A61N1/372 , A61N1/378 , H02J7/00 , H02J7/04
Abstract: In some examples, a medical device system includes a first implantable medical device. The first implantable medical device (IMD) may comprise circuitry configured to at least one of deliver a therapy to a patient or sense a physiological signal from the patient; generate stimulation deliverable to a patient; a first rechargeable power source; and a secondary coil coupled to the first rechargeable power source, the secondary coil configured to charge the first rechargeable power source via inductive coupling with a primary coil of an external charging device. The medical device system may comprise processing circuitry configured to control charging of the first rechargeable power source based on a charge state of a second rechargeable power source of a second IMD.
-
公开(公告)号:US20200376256A1
公开(公告)日:2020-12-03
申请号:US16947945
申请日:2020-08-25
Applicant: Medtronic, Inc.
Inventor: Brad C. Tischendorf , John E. Kast , Thomas P. Miltich , Gordon O. Munns , Randy S. Roles , Craig L. Schmidt , Joseph J. Viavattine , Christian S. Nielsen , Prabhakar A. Tamirisa , Anthony M. Chasensky , Markus W. Reiterer , Chris J. Paidosh , Reginald D. Robinson , Bernard Q. Li , Erik R. Scott , Phillip C. Falkner , Xuan K. Wei , Eric H. Bonde
Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
-
公开(公告)号:US20190282818A1
公开(公告)日:2019-09-19
申请号:US16412069
申请日:2019-05-14
Applicant: Medtronic, Inc.
Inventor: Eric H. Bonde , John E. Kast , Erik R. Scott , Xuan K. Wei
Abstract: In some examples, an implantable medical device includes an implantable housing, a neurostimulator within the housing, a plurality of electrodes, an implantable lead coupled to the housing, and an actuator formed with the housing. The implantable lead includes at least one electrode of the plurality of electrodes and one or more conductors coupling the at least one electrode to the neurostimulator. The actuator is configured to cause at least a portion of the implantable lead to deflect.
-
公开(公告)号:US10258804B2
公开(公告)日:2019-04-16
申请号:US15343949
申请日:2016-11-04
Applicant: Medtronic, Inc.
Inventor: Erik R. Scott , Kunal Paralikar
IPC: A61N1/37 , A61N1/378 , A61F7/00 , A61B5/00 , A61B5/01 , A61M5/172 , A61M5/44 , A61N5/06 , A61M5/142
Abstract: Devices, systems, and techniques are configured for cooling tissue during recharge of an implantable medical device (IMD) battery. In one example, a method includes charging, by an inductive charger, a rechargeable battery of an implantable medical device (IMD) within a patient, wherein the IMD comprises a housing that houses the rechargeable battery, and wherein a primary coil of the inductive charger is positioned above a region of skin of the patient proximate to the IMD. The example method further includes cooling, by a heat exchanger, the region of skin below a normal ambient surface temperature of the region of skin, wherein the heat exchanger is interposed between the primary coil and the region of skin.
-
公开(公告)号:US20180126177A1
公开(公告)日:2018-05-10
申请号:US15343949
申请日:2016-11-04
Applicant: Medtronic, Inc.
Inventor: Erik R. Scott , Kunal Paralikar
CPC classification number: A61N1/3787 , A61B5/01 , A61B5/4836 , A61B5/6867 , A61B2560/0219 , A61F7/0085 , A61F2007/0052 , A61F2007/0096 , A61M5/14276 , A61M5/172 , A61M5/44 , A61M2205/3368 , A61M2205/3523 , A61M2205/502 , A61M2205/8206 , A61N5/0601
Abstract: Devices, systems, and techniques are configured for cooling tissue during recharge of an implantable medical device (IMD) battery. In one example, a method includes charging, by an inductive charger, a rechargeable battery of an implantable medical device (IMD) within a patient, wherein the IMD comprises a housing that houses the rechargeable battery, and wherein a primary coil of the inductive charger is positioned above a region of skin of the patient proximate to the IMD. The example method further includes cooling, by a heat exchanger, the region of skin below a normal ambient surface temperature of the region of skin, wherein the heat exchanger is interposed between the primary coil and the region of skin.
-
公开(公告)号:US09931107B2
公开(公告)日:2018-04-03
申请号:US14098621
申请日:2013-12-06
Applicant: Medtronic, Inc.
Inventor: Brad C. Tischendorf , Eric H. Bonde , Phillip C. Falkner , John E. Kast , Randy S. Roles , Erik R. Scott , Todd V. Smith , Xuan K. Wei , Anthony M. Chasensky , Michael J. Ebert , Shawn C. Kelley , Gabriela C. Molnar , Richard T. Stone
CPC classification number: A61B17/00234 , A61N1/02 , A61N1/05 , A61N1/0551 , A61N1/36 , A61N1/36007 , A61N1/36021 , A61N1/3605 , A61N1/36053 , A61N1/36057 , A61N1/36067 , A61N1/36071 , A61N1/36139 , A61N1/37205 , A61N1/37211 , A61N1/37223 , A61N1/37235 , A61N1/37247 , A61N1/37252 , A61N1/3727 , A61N1/375 , A61N1/3754 , A61N1/3756 , A61N1/3787 , F04C2270/0421
Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
-
公开(公告)号:US09882420B2
公开(公告)日:2018-01-30
申请号:US15464066
申请日:2017-03-20
Applicant: Medtronic, Inc.
Inventor: Peng Cong , Venkat R. Gaddam , David P. Olson , Erik R. Scott , Todd V. Smith , Leroy L. Perz
CPC classification number: H02J7/047 , A61N1/3787 , G01J5/0887 , G01J5/089 , G01K11/006 , G01K11/20 , H02J7/007 , H02J7/0091 , H02J7/025
Abstract: Devices, systems, and techniques for monitoring the temperature of a device used to charge a rechargeable power source are disclosed. Implantable medical devices may include a rechargeable power source that can be transcutaneously charged. The temperature of an external charging device and/or an implantable medical device may be monitored to control the temperature exposure to patient tissue. In one example, a temperature sensor may sense a temperature of a portion of a device, wherein the portion is non-thermally coupled to the temperature sensor. A processor may then control charging of the rechargeable power source based on the sensed temperature.
-
公开(公告)号:US20170007853A1
公开(公告)日:2017-01-12
申请号:US15204430
申请日:2016-07-07
Applicant: Medtronic, Inc.
Inventor: Jamu K. Alford , Erik R. Scott , John D. Welter , John R. LaLonde , Yohan Kim
CPC classification number: A61N7/00 , A61B5/01 , A61B5/0205 , A61B5/02055 , A61B5/024 , A61B5/0816 , A61B5/1118 , A61B5/14542 , A61B5/14546 , A61B5/4848 , A61B5/6804 , A61B5/6831 , A61B8/02 , A61B8/04 , A61B8/08 , A61B8/4236 , A61N2007/0026 , A61N2007/0052 , A61N2007/0078
Abstract: In some examples, a system includes a flexible ultrasound device configured to be attached to an external surface of a patient proximate to an organ of the patient to deliver ultrasound configured to modulate nerve tissue of the patient at the organ. The system further comprises one or more sensors configured to sense one or more physiological parameters indicative of at least one of a symptom treatable by, or a side effect of, the neuromodulation, and processing circuitry configured to control the delivery of ultrasound during an ambulatory period of the patient, and monitor the least one of the symptom or the side effect during the ambulatory period, based on the one or more physiological parameters. The organ may be the spleen and the ultrasound may at least one of regulate the autoimmune system of the patient, or reduce an inflammation response of the patient.
Abstract translation: 在一些示例中,系统包括柔性超声波装置,其被配置为附接到靠近患者器官的患者的外表面,以递送构造成调节患者在器官处的神经组织的超声波。 该系统还包括一个或多个传感器,其被配置为感测指示神经调节可治疗的症状或副作用中的至少一种的一个或多个生理参数,以及被配置成在动态期间控制超声波传送的处理电路 并且基于所述一个或多个生理参数来监测所述步行期间中的症状或副作用中的至少一个。 器官可以是脾脏,并且超声可以至少一种调节患者的自身免疫系统,或减少患者的炎症反应。
-
公开(公告)号:US20150263392A1
公开(公告)日:2015-09-17
申请号:US14657759
申请日:2015-03-13
Applicant: Medtronic, Inc.
Inventor: Erik R. Scott , Gaurav Jain
IPC: H01M10/44 , H01M4/131 , H01M10/0525 , H01M10/0569 , H01M4/485 , H01M4/583
CPC classification number: H01M10/446 , H01M4/131 , H01M4/485 , H01M4/583 , H01M10/0525 , H01M10/0569 , H01M2010/4292 , H01M2300/0028 , Y02E60/122 , Y02P70/54 , Y10T29/49108
Abstract: A method for producing a battery includes providing a battery having a positive electrode, a negative electrode, and an electrolyte that includes a solvent and a salt. The capacity of the negative electrode is less than that of the positive electrode and the negative electrode includes an active material having an average potential versus a lithium reference electrode of greater than approximately 0.2 volts. The method also includes applying an initial charge to the battery at a voltage that is greater than a fully charged voltage of the battery for a sufficient amount of time to cause at least a portion of the solvent to undergo a reduction reaction. The step of applying an initial charge to the battery acts to increase the irreversible capacity loss of the battery during the initial charge and provides the battery with enhanced tolerance to deep discharge conditions.
Abstract translation: 电池的制造方法包括提供具有正极,负极和包含溶剂和盐的电解质的电池。 负极的容量小于正极的容量,负极包括具有大于约0.2伏特的平均电位相对于锂参比电极的活性材料。 该方法还包括以大于电池的完全充电电压的电压对电池施加初始电荷足够的时间以使至少一部分溶剂进行还原反应。 向电池施加初始电荷的步骤用于增加初始充电期间电池的不可逆容量损失,并为电池提供增强的对深放电条件的容限。
-
-
-
-
-
-
-
-
-